文献速递心境障碍精神分裂症与精神病性障碍

家族遗传风险评分与重性抑郁、双相、其他非情感性精神病及精神分裂症诊断轨迹的关系

Relationship of Family Genetic Risk Score With Diagnostic Trajectory in a Swedish National Sample of Incident Cases of Major Depression, Bipolar Disorder, Other Nonaffective Psychosis, and Schizophrenia.
PubMed 文献 · JAMA Psychiatry · 2023-01-01

该研究基于瑞典全国登记数据库的纵向人群队列(N=4 171 120),纳入首次诊断为重性抑郁、双相障碍、其他非情感性精神病或精神分裂症且随访中至少再获一次四类诊断之一的个体(共269 097例),评估家族遗传风险评分(FGRS)与诊断稳定性的关联。结果显示诊断稳定性以重性抑郁最高(91.4%),精神分裂症次之(73.2%),双相障碍63.6%,其他非情感性精神病42.1%;初始诊断的高FGRS与诊断稳定相关,而最终诊断的高FGRS及初始诊断的低FGRS与诊断改变相关。

要点

  • 诊断稳定性:重性抑郁91.4%>精神分裂症73.2%>双相障碍63.6%>其他非情感性精神病42.1%。
  • 初始诊断高FGRS与诊断稳定相关;最终诊断高FGRS且初始诊断低FGRS与诊断改变相关。
  • 遗传风险最高5%者发生特定诊断转换的OR≥1.75,如双相FGRS预测重性抑郁转双相OR=2.60。

核心结论

  • 重性抑郁、双相障碍、其他非情感性精神病和精神分裂症的遗传风险因素与这四种疾病的诊断轨迹存在有意义且系统性的关联。
  • 随时间推移,临床诊断与遗传风险谱趋于一致,为这些诊断构念提供了遗传学验证。
  • 诊断不稳定的初始病例比诊断稳定者遗传异质性更高。

研究设计与样本

  • 纵向人群队列研究,样本来自瑞典全国医学登记,总队列N=4 171 120。
  • 纳入首次诊断为重性抑郁(n=235 095)、双相障碍(n=11 681)、其他非情感性精神病(n=16 009)或精神分裂症(n=6 312)且随访中至少再获一次四类诊断之一的个体,共269 097例。
  • 平均(SD)随访13.1(5.9)年,至平均(SD)年龄48.4(12.3)岁;数据收集自1973年1月至2018年12月,分析于2022年8月至9月。
  • 暴露为基于一至五级亲属患病风险计算的FGRS(控制同居效应),主要结局为最终诊断(重性抑郁、双相障碍、其他非情感性精神病或精神分裂症)。

主要发现

  • 269 097例中女性173 061例(64.3%),首次登记平均(SD)年龄35.1(11.9)岁。
  • 诊断稳定性:重性抑郁214 794例(91.4%)、精神分裂症4 621例(73.2%)、双相障碍7 428例(63.6%)、其他非情感性精神病6 738例(42.1%)。
  • 第二常见最终诊断:重性抑郁→双相障碍15 506例(6.6%)、精神分裂症→其他非情感性精神病1 110例(17.6%)、双相障碍→重性抑郁2 681例(23.0%)、其他非情感性精神病→精神分裂症4 401例(27.5%)。
  • 初始诊断高FGRS与诊断稳定相关;最终诊断高FGRS且初始诊断低FGRS与诊断改变相关。
  • 多变量模型中,遗传风险最高5%者以下诊断转换的OR≥1.75:重性抑郁FGRS预测其他非情感性精神病→重性抑郁(OR=1.91,95%CI 1.59-2.29)和精神分裂症→重性抑郁(OR=2.45,95%CI 1.64-3.68);双相FGRS预测重性抑郁→双相(OR=2.60,95%CI 2.47-2.73)、其他非情感性精神病→双相(OR=2.16,95%CI 1.85-2.52)和精神分裂症→双相(OR=2.20,95%CI 1.39-3.49);其他非情感性精神病FGRS预测重性抑郁→其他非情感性精神病(OR=1.80,95%CI 1.62-2.02)、重性抑郁→精神分裂症(OR=1.95,95%CI 1.58-2.41)和双相→精神分裂症(OR=1.89,95%CI 1.39-2.56);精神分裂症FGRS预测重性抑郁→精神分裂症(OR=1.80,95%CI 1.46-2.23)和双相→精神分裂症(OR=1.75,95%CI 1.25-2.45)。

关键数值与推荐

  • 诊断稳定性定义为首次诊断与最终诊断一致的比例,重性抑郁91.4%、精神分裂症73.2%、双相障碍63.6%、其他非情感性精神病42.1%。
  • 遗传风险最高5%者发生特定诊断转换的OR≥1.75,具体数值见主要发现。

临床怎么用

  • 家族遗传风险评分可辅助预测重性抑郁、双相障碍、其他非情感性精神病和精神分裂症的诊断稳定性与转换方向。
  • 对初始诊断后遗传风险提示可能转换的患者,可加强纵向监测与早期干预。
  • 遗传风险谱与临床诊断随时间趋同,支持将遗传信息纳入诊断评估以验证诊断构念。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Since its inception under Kraepelin in the modern era, diagnostic stability and familial/genetic risk have been among the most important psychiatric nosologic validators. OBJECTIVE: To assess the interrelationships of family genetic risk score (FGRS) with diagnostic stability or diagnostic change in major depression (MD), bipolar disorder (BD), other nonaffective psychosis (ONAP), and schizophrenia. DESIGN, SETTING, AND PARTICIPANTS: This longitudinal population-based cohort (N = 4 171 120) included individuals with incident cases of MD (n = 235 095), BD (n = 11 681), ONAP (n = 16 009), and schizophrenia (n = 6312) who had at least 1 further diagnosis of the 4 disorders during follow-up, as assessed from Swedish national medical registries, observed over a mean (SD) of 13.1 (5.9) years until a mean (SD) age of 48.4 (12.3) years. Data were collected from January 1973 to December 2018, and data were analyzed from August to September 2022. EXPOSURES: FGRS for MD, BD, ONAP, and schizophrenia, calculated from morbidity risks for disorders in first-degree through fifth-degree relatives, controlling for cohabitation effects. MAIN OUTCOMES AND MEASURES: Final diagnostic outcome of MD, BD, ONAP, or schizophrenia. RESULTS: Of 269 097 included individuals, 173 061 (64.3%) were female, and the mean (SD) age at first registration was 35.1 (11.9) years. Diagnostic stability was highest for MD (214 794 [91.4%]), followed by schizophrenia (4621 [73.2%]), BD (7428 [63.6%]), and ONAP (6738 [42.1%]). The second most common final diagnosis for each of these MD, schizophrenia, BD, and ONAP were BD (15 506 [6.6%]), ONAP (1110 [17.6%]), MD (2681 [23.0%]), and schizophrenia (4401 [27.5%]), respectively. A high FGRS for the incident diagnosis was consistently associated with diagnostic stability, while a high FGRS for the final diagnosis and a low FGRS for the incident diagnosis was associated with diagnostic change. In multivariate models, those in the upper 5% of genetic risk had an odds ratio (OR) of 1.75 or greater for the following diagnostic transition: for MD FGRS, ONAP to MD (OR, 1.91; 95% CI, 1.59-2.29) and schizophrenia to MD (OR, 2.45; 95% CI, 1.64-3.68); for BD FGRS, MD to BD (OR, 2.60; 95% CI, 2.47-2.73), ONAP to BD (OR, 2.16; 95% CI, 1.85-2.52), and schizophrenia to BD (OR, 2.20; 95% CI, 1.39-3.49); for ONAP FGRS, MD to ONAP (OR, 1.80; 95% CI, 1.62-2.02), MD to schizophrenia (OR, 1.95; 95% CI, 1.58-2.41), and BD to schizophrenia (OR, 1.89; 95% CI, 1.39-2.56); and for schizophrenia FGRS, MD to schizophrenia (OR, 1.80; 95% CI, 1.46-2.23), and BD to schizophrenia (OR, 1.75; 95% CI, 1.25-2.45). FGRS profiles for incident cases confirmed at final diagnosis were more homogenous than genetic profiles for those who changed diagnoses. CONCLUSIONS AND RELEVANCE: In a large population-based longitudinal cohort, the genetic risk factors for MD, BD, ONAP, and schizophrenia were meaningfully and systematically associated with the diagnostic trajectories of these 4 disorders. Over time, clinical diagnosis and genetic risk profiles became increasingly consilient, thereby providing genetic validation of these diagnostic constructs. Diagnostically unstable incident cases were more genetically heterogeneous than those who were diagnostically stable over time.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kendler KS, Ohlsson H, Sundquist J, et al. Relationship of Family Genetic Risk Score With Diagnostic Trajectory in a Swedish National Sample of Incident Cases of Major Depression, Bipolar Disorder, Other Nonaffective Psychosis, and Schizophrenia. JAMA Psychiatry. 2023. PMID: 36696095. doi:10.1001/jamapsychiatry.2022.4676

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。